More than 1,200 studies looking at treatment and prevention of coronavirus are often too small to provide conclusive results and are focusing too much on one potential therapy, a new analysis reveals. Commissioned by STAT News, the report found that one in every six clinical trials studied the anti-malaria drugs hydroxychloroquine or chloroquine despite thin … Read more
Prescriptions for two anti-malaria drugs to treat the novel coronavirus soared by hundreds of thousands in March, a new study suggests. Typically, only about 380,000 people are prescribed hydroxychloroquine and its analog chloroquine to treat malaria, lupus and rheumatoid arthritis. However, in March, President Donald Trump hailed the drug, which also is used to treat arthritis … Read more
After repeated failures in previous research, a new study suggests hydroxychloroquine can improve survival odds for some coronavirus patients. Hospitalized coronavirus patients given hydroxychloroquine were 50 percent less likely to die of the brutal infection than those who did not receive the drug in a Henry Ford Health System study of 2,541 people. It comes … Read more
US researchers are still testing whether hydroxychloroquine can prevent coronavirus despite study that found taking it after exposure does not block the infection Duke University’s HERO trial aims to test whether hydroxychloroquine given before coronavirus exposure can prevent infection The study, intended to conclude in July, was planned to include 15,000 health care workers. Only … Read more
A ‘scandalous’ and now retracted medical study which warned against using a drug championed by Donald Trump has flared accusations of political-point scoring. The paper’s claim that hydroxychloroquine increases the risk of death in Covid-19 patients has been used by rivals as a stick to beat the US President, who has himself been taking the drug … Read more
Hydroxychloroquine does NOT treat Covid-19: Biggest study into the Donald Trump-backed anti-malaria drug is ended with ‘immediate effect’ after researchers found it made no difference Oxford University scientists pulled the drug from the RECOVERY trial today Results showed it had no benefit on NHS patients hospitalised with the virus Scientists running the trial has urged … Read more
The authors of a momentous study that claimed that hydroxychloroquine raised the risks of death for coronavirus patients treated the controversial malaria drug have retracted their research. The retraction was published in the Lancet on Thursday, and comes just two days after the medical journal posted an ‘expression of concern.’ Along with the publication, more … Read more
Taking hydroxychloroquine after being exposed to someone with the novel coronavirus does not prevent you from contracting the disease, a new study finds. Researchers looked at 821 people who were exposed to the virus either through their line of worker as a healthcare professional, or from someone at home. Hydroxychloroquine – used to treat malaria, … Read more
WHO will RESUME trials of hydroxychloroquine to treat coronavirus as experts question studies that suggested the malaria drug raises risks of death On May 25, the WHO said it had paused the hydroxychloroquine arms of its international study on potential COVID-19 drugs The moratorium came after a study in the Lancet suggested patients who took … Read more
The US has sent two million doses of the anti-malaria drug hydroxychloroquine to Brazil to use against the novel coronavirus, the two governments said on Sunday. In a joint statement, the two countries said the medication will be used as a prophylactic for healthcare workers in Brazil as well as a treatment for Brazilians who … Read more